Your browser doesn't support javascript.
loading
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma.
Dimopoulos, Meletios A; Jakubowiak, Andrzej J; McCarthy, Philip L; Orlowski, Robert Z; Attal, Michel; Bladé, Joan; Goldschmidt, Hartmut; Weisel, Katja C; Ramasamy, Karthik; Zweegman, Sonja; Spencer, Andrew; Huang, Jeffrey S Y; Lu, Jin; Sunami, Kazutaka; Iida, Shinsuke; Chng, Wee-Joo; Holstein, Sarah A; Rocci, Alberto; Skacel, Tomas; Labotka, Richard; Palumbo, Antonio; Anderson, Kenneth C.
Afiliação
  • Dimopoulos MA; Hematology & Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece. mdimop@med.uoa.gr.
  • Jakubowiak AJ; University of Chicago Medical Center, Chicago, IL, USA.
  • McCarthy PL; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Orlowski RZ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Attal M; Hematology Department, University Hospital Purpan, Toulouse, France.
  • Bladé J; Hematology Department, Hospital Clinic, Institut de Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
  • Goldschmidt H; Department of Internal Medicine V, University Medical Hospital and National Center of Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
  • Weisel KC; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ramasamy K; Oxford University Hospitals, NHS Foundation Trust, Oxford, UK.
  • Zweegman S; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, VU University Amsterdam, Amsterdam, The Netherlands.
  • Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, Australia.
  • Huang JSY; National Taiwan University, Taipei, Taiwan.
  • Lu J; Department of Hematology, Peking University People's Hospital and Peking University Institute of Hematology, Beijing, China.
  • Sunami K; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Chng WJ; Department of Haematology-Oncology, National University Cancer Institute, National University Health System, and Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Holstein SA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
  • Rocci A; Department of Haematology, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
  • Skacel T; Faculty of Biology, Medicine and Health, School of Medical Science, Division of Cancer Science, University of Manchester, Manchester, UK.
  • Labotka R; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Palumbo A; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Anderson KC; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
Blood Cancer J ; 10(2): 17, 2020 02 13.
Article em En | MEDLINE | ID: mdl-32054831

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Transplante de Células-Tronco Hematopoéticas / Quimioterapia de Manutenção / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Transplante de Células-Tronco Hematopoéticas / Quimioterapia de Manutenção / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article